|
Index of reports
> Cases resulting in death (16)
> Cases with Rhabdomyolysis (2)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in death where reactions include rhabdomyolysis.
Adverse event in 69 year old female receiving Zetia (Ezetimibe)
Reported by a individual with unspecified qualification from United Kingdom on 2007-01-29
Patient: 69 year old female
Adverse reactions / side effects: Rhabdomyolysis, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Ibuprofen
Dosage: 400 mg 2x per 1 day; oral
Administration route: Oral
Indication: Osteoarthritis
Start date: 2006-04-05
Crestor
Dosage: 10mg frequency unknown; oral
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Zetia
Dosage: 10mg frequency unknown; oral
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Other drugs received by patient: Spironolactone; Cozaar Comp (Hydrochlorothiazide / Losartan Potassium); Metformin HCL; Rosiglitazone; Bisocard (Bisoprolol); Aspirin
Adverse event in 69 year old female receiving Zetia (Ezetimibe)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-01-22
Patient: 69 year old female
Adverse reactions / side effects: Rhabdomyolysis, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Rosuvastatin Calcium
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2004-01-01
Ibuprofen
Administration route: Oral
Indication: Osteoarthritis
Start date: 2006-04-05
Other drugs received by patient: Spironolactone; Hydrochlorothiazide and Losartan Potassium; Metformin; Rosiglitazone Maleate; Bisoprolol; Aspirin
|
